Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 13 hours 57 min ago

Historic Approval for MASH, CAR-Ts in the Spotlight

Wed, 03/20/2024 - 02:00
Historic Approval for MASH, CAR-Ts in the Spotlight 3/20/2024

What Another Trump Presidency Could Mean for Big Pharma

Wed, 03/20/2024 - 02:00
What Another Trump Presidency Could Mean for Big Pharma 3/20/2024

Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label

Wed, 03/20/2024 - 02:00
Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label 3/20/2024

How to Talk About Politics at Work

Wed, 03/20/2024 - 02:00
How to Talk About Politics at Work 3/20/2024

Novo Invests $556M in China Operations to Boost Manufacturing Capacity

Wed, 03/20/2024 - 02:00
Novo Invests $556M in China Operations to Boost Manufacturing Capacity 3/20/2024

Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA

Wed, 03/20/2024 - 02:00
Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA 3/20/2024

EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies

Wed, 03/20/2024 - 02:00
EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies 3/20/2024

Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC

Wed, 03/20/2024 - 02:00
Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC 3/20/2024

With the Salary Growth Rate Slowing, Should Biopharma Employees Look for New Jobs?

Wed, 03/20/2024 - 02:00
With the Salary Growth Rate Slowing, Should Biopharma Employees Look for New Jobs? 3/20/2024

AstraZeneca Buys Fusion in Potential $2B Deal, Joins Radiopharma Buying Spree

Tue, 03/19/2024 - 02:00
AstraZeneca Buys Fusion in Potential $2B Deal, Joins Radiopharma Buying Spree 3/19/2024

Bayer’s Veozah Rival Hits Goals in Long-Term Phase III Hot Flash Study

Tue, 03/19/2024 - 02:00
Bayer’s Veozah Rival Hits Goals in Long-Term Phase III Hot Flash Study 3/19/2024

Engrail Raises $157M in Oversubscribed Series B to Move Neuro Pipeline Forward

Tue, 03/19/2024 - 02:00
Engrail Raises $157M in Oversubscribed Series B to Move Neuro Pipeline Forward 3/19/2024

Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission

Tue, 03/19/2024 - 02:00
Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission 3/19/2024

Orchard Wins FDA Approval for First Gene Therapy for Rare Pediatric Disease

Tue, 03/19/2024 - 02:00
Orchard Wins FDA Approval for First Gene Therapy for Rare Pediatric Disease 3/19/2024

Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch

Tue, 03/19/2024 - 02:00
Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch 3/19/2024

Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis

Tue, 03/19/2024 - 02:00
Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis 3/19/2024

Report: 2024 U.S. Life Sciences Salary Trends

Tue, 03/19/2024 - 02:00
Report: 2024 U.S. Life Sciences Salary Trends 3/19/2024

AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need

Mon, 03/18/2024 - 02:00
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need 3/18/2024

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data

Mon, 03/18/2024 - 02:00
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data 3/18/2024

J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline

Mon, 03/18/2024 - 02:00
J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline 3/18/2024